States Fight Telehealth Abortion Access

Since the Supreme Courts Dobbs decision, telehealth access to abortion pills like mifepristone has expanded, but anti-abortion groups and state attorneys general are intensifying legal battles to halt it. Louisianas attorney general sued the FDA, targeting a 2023 rule allowing doctors to prescribe and mail the drug without in-person visits. The lawsuit includes a woman who claims she was pressured into taking it, and officials seek a court order to block nationwide access. Other states are implementing similar restrictions, treating mifepristone like a controlled substance. Lawmakers cite safety concerns from a non-peer-reviewed report, but experts assert the real rate of serious side effects is under 0.5% based on decades of studies. Doctors and groups like the American College of Obstetricians and Gynecologists argue telehealth skips unnecessary steps and risks are low before ten weeks. This fight could reshape access nationwide if courts side with the states, but ongoing research continues to highlight the drugs safety for early pregnancies, miscarriages, and other uses.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/cf94f90bb802b649